CAI Is a Potent Inhibitor of Neovascularization and Imparts Neuroprotection in a Mouse Model of Ischemic Retinopathy

Overview of attention for article published in Investigative Ophthalmology & Visual Science, October 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent: 7 patents

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

CAI-based systems and methods for the localized treatment of uveitis

Grant US-9629826-B2

United States of America

25 Apr 2017

Use of Carboxyamidotriazole (CAI) orotate in macular degeneration

Grant US-8420658-B2

United States of America

16 Apr 2013

Use of Carboxyamidotriazole (CAI) orotate in macular degeneration

Grant AU-2007328027-B2

Australia

15 Nov 2012

The uses of the carboxy-amido-triazole compounds and salts thereof

Grant AU-2007312840-B2

Australia

05 Jul 2012

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.